<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Chuang MA</submitter><funding>Roche</funding><funding>National Health and Medical Research Council</funding><funding>Royal Australasian College of Physicians</funding><pagination>100933</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8728427</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>38</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>To understand the economic impact of an accelerated 0/1-hour high-sensitivity troponin-T (hs-cTnT) protocol.&lt;h4>Objective&lt;/h4>To conduct a patient-level economic analysis of the RAPID-TnT randomised trial in patients presenting with suspected acute coronary syndrome (ACS).&lt;h4>Methods&lt;/h4>An economic evaluation was conducted with 3265 patients randomised to either the 0/1-hour hs-cTnT protocol (n = 1634) or the conventional 0/3-hour standard-of-care protocol (n = 1631) with costs reported in Australian dollars. The primary clinical outcome was all-cause mortality or new/recurrent myocardial infarction.&lt;h4>Results&lt;/h4>Over 12-months, mean per patient costs were numerically higher in the 0/1-hour arm compared to the conventional 0/3-hour arm (by $472.49/patient, 95% confide</pubmed_abstract><journal>International journal of cardiology. Heart &amp; vasculature</journal><pubmed_title>Cost effectiveness of a 1-hour high-sensitivity troponin-T protocol: An analysis of the RAPID-TnT trial.</pubmed_title><pmcid>PMC8728427</pmcid><funding_grant_id>GNT1124471</funding_grant_id><pubmed_authors>Blyth A</pubmed_authors><pubmed_authors>Quinn S</pubmed_authors><pubmed_authors>Karnon J</pubmed_authors><pubmed_authors>Nguyen MT</pubmed_authors><pubmed_authors>Chew DP</pubmed_authors><pubmed_authors>Horsfall M</pubmed_authors><pubmed_authors>French JK</pubmed_authors><pubmed_authors>Briffa T</pubmed_authors><pubmed_authors>Chuang MA</pubmed_authors><pubmed_authors>Lambrakis K</pubmed_authors><pubmed_authors>Seshadri A</pubmed_authors><pubmed_authors>Cullen LA</pubmed_authors><pubmed_authors>Gnanamanickam ES</pubmed_authors></additional><is_claimable>false</is_claimable><name>Cost effectiveness of a 1-hour high-sensitivity troponin-T protocol: An analysis of the RAPID-TnT trial.</name><description>&lt;h4>Background&lt;/h4>To understand the economic impact of an accelerated 0/1-hour high-sensitivity troponin-T (hs-cTnT) protocol.&lt;h4>Objective&lt;/h4>To conduct a patient-level economic analysis of the RAPID-TnT randomised trial in patients presenting with suspected acute coronary syndrome (ACS).&lt;h4>Methods&lt;/h4>An economic evaluation was conducted with 3265 patients randomised to either the 0/1-hour hs-cTnT protocol (n = 1634) or the conventional 0/3-hour standard-of-care protocol (n = 1631) with costs reported in Australian dollars. The primary clinical outcome was all-cause mortality or new/recurrent myocardial infarction.&lt;h4>Results&lt;/h4>Over 12-months, mean per patient costs were numerically higher in the 0/1-hour arm compared to the conventional 0/3-hour arm (by $472.49/patient, 95% confide</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Feb</publication><modification>2025-04-05T10:53:49.929Z</modification><creation>2022-02-11T15:19:58.078Z</creation></dates><accession>S-EPMC8728427</accession><cross_references><pubmed>35024428</pubmed><doi>10.1016/j.ijcha.2021.100933</doi></cross_references></HashMap>